Study | Study time | Country | Age | Gender (male/female) | No. of case/control | Sample size | Study design |
---|---|---|---|---|---|---|---|
Olszewska-Czyz, I 2022 [17] | NM | Poland | 25–62 | 49/51 | 50/50 | 100 | Case–control |
Costantini, E 2020 [22] | NM | Italy | 25–60 | 14/28 | 21/21 | 42 | Case–control |
Abreu, O 2016 [30] | 2014.05–2014.07 | Puerto Rican | 35–64 | 10/28 | 19/19 | 38 | Case–control |
Alzahrani, A 2021 [31] | 2020.01–2020.11 | Saudi Arabia | 40.01 ± 7.73 | 46.3%/53.7% | 60/63 | 123 | Case–control |
Anbarcioglu, E 2019 [32] | 2012–2013 | Turkey | 21–47 | 58/71 | 47/55/27 | 129 | Case–control |
Gao, W 2020 [33] | 2014.12–2015.06 | China | 30–70 | 178/182 | 120/120/120 | 360 | RCT |
Ketharanathan, V 2019 [34] | NM | Tamil and Norway | 30–70 | 92/0 | 44/48 | 92 | Case–control |
Laky, M 2017 [35] | 2008–2010 | Vienna | 28–42 | 20/38 | 29/29 | 58 | Case–control |
Liu, K 2010 [36] | 2006.11–2007.02 | China | 16–34 | 8/11 | 19 | 19(12) | Non-RCT |
Miley, D 2009 [37] | 2007.06—2008.02 | America | 50–80 | 6/16/17/12 | 23/28 | 51 | Cross-sectional |
Miricescu, D 2014 [38] | NM | Romania | 51.26 ± 7.4 | 16/34 | 25/25 | 50 | Case–control |
Pai, S 2021 [39] | NM | India | 30–60 | NM | 30/30 | 60 | Non-RCT |
Perayil, J 2015 [40] | 2012.11—2013.12 | India | 35–55 | NM | 36/41 | 77 | Non-RCT |
Perić, M 2020 [41] | 2017.04–2018.10 | Brussels | NM | 19/7 | 12/14 | 26(21) | RCT |
Pradhan, S 2021 [42] | 2019.02–2019.08 | Nepal | 25–54 | 56/24 | 40/40 | 80 | Cross-sectional |
Rafique, S 2019 [43] | NM | Pakistan | 18–40 | 44%/56% | 75/75 | 150 | Case–control |